Praveen Vikas

8PUBLICATIONS
69CO-AUTHORS
Medical infection agents (incl. prions)Cancer therapy (excl. chemotherapy and radiation therapy)Social and community informaticsCancer diagnosisApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jan 05, 2023
Mismatch Repair and Microsatellite Instability Testing for Immune Checkpoint Inhibitor Therapy: ASCO Endorsement of College of American Pathologists Guideline.

Praveen Vikas, Hans Messersmith, Carolyn Compton

|Jun 21, 2022
Use of Immune Checkpoint Inhibitors in the Treatment of High-Risk, Early-Stage Triple-Negative Breast Cancer: ASCO Guideline Rapid Recommendation Update Q and A.

Praveen Vikas, Larissa A Korde, Mark R Somerfield

|May 19, 2022
Making National Cancer Institute-Designated Comprehensive Cancer Center Knowledge Accessible to Community Oncologists via an Online Tumor Board: Longitudinal Observational Study.

Maitri Kalra, Elizabeth Henry, Kelly McCann

|Jan 11, 2022
Natural and Synthetic Estrogens in Chronic Inflammation and Breast Cancer.

Chandra K Maharjan, Jiao Mo, Lei Wang

|Nov 01, 2021
Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: ASCO Guideline Update.

Bryan J Schneider, Jarushka Naidoo, Bianca D Santomasso

|Nov 01, 2021
Management of Immune-Related Adverse Events in Patients Treated With Chimeric Antigen Receptor T-Cell Therapy: ASCO Guideline.

Bianca D Santomasso, Loretta J Nastoupil, Sherry Adkins

Pageof 2

Frequent Collaborators

2 joint publications

Mark R Somerfield

2 joint publications

Leslie Fecher

2 joint publications

Marianne J Davies

2 joint publications

Ian Chau